Search
N,N-dimethylarginine
go.drugbank.com/drugs/DB01686ExperimentalIt is a metabolic by-product of continual protein modification processes in the cytoplasm of all human cells which is closely related to L-arginine, a conditionally-essential amino acid. … ADMA interferes with L-arginine in the production of nitric oxide, a key chemical to endothelial and hence cardiovascular health.
Synonyms: guanidino-N,N-dimethylarginine, N(G),N(G)-DimethylarginineButerizine
go.drugbank.com/drugs/DB20973ExperimentalButerizine is a small molecule drug. The usage of the INN stem '-rizine' in the name indicates that Buterizine is a antihistaminic/cerebral (or peripheral) vasodilator.
Lifarizine
go.drugbank.com/drugs/DB20533ExperimentalLifarizine is a small molecule drug. The usage of the INN stem '-rizine' in the name indicates that Lifarizine is a antihistaminic/cerebral (or peripheral) vasodilator.
Exicorilant
go.drugbank.com/drugs/DB16162InvestigationalExicorilant is under investigation in clinical trial NCT03437941 (Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With Mcrpc).
Dopastatin
go.drugbank.com/drugs/DB16144InvestigationalDopastatin is under investigation in clinical trial NCT04335357 (TBR-760 in Adult Patients With Non-functioning Pituitary Adenomas).
Tamnorzatinib
go.drugbank.com/drugs/DB19201InvestigationalTamnorzatinib is under investigation in clinical trial NCT03176277 (A Study of ONO-7475 in Patients With Acute Leukemias).
Synonyms: 3-quinolinecarboxamide, n-(5-((6,7-dimethoxy-4-quinolinyl)oxy)-2-pyridinyl)-1,2,5,6,7,8-hexahydro-2,5-dioxo-1-phenyl-, N-(5-((6,7-dimethoxyquinolin-4-yl)oxy)pyridin-2-yl)-2,5-dioxo-1-phenyl-1,2,5,6,7,8-hexahydroquinoline-3-carboxamideFarampator
go.drugbank.com/drugs/DB15012InvestigationalFarampator is under investigation in clinical trial NCT00113022 (Org 24448 to Treat Major Depression).
Sulfate ion
go.drugbank.com/drugs/DB14546InvestigationalMixtures: Telom-X-gene, VAMIN 14 IV AMINOASIT SOLÜSYONU, 500 MLSynonyms: Sulfate ion, Sulfuric acid ion(2-)Rogaratinib
go.drugbank.com/drugs/DB15078InvestigationalRogaratinib is under investigation in clinical trial NCT03762122 (Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC)).